Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy

被引：11
|
作者：
Chin, Collin K. [1 ,2 ]
Hall, Sara [1 ,2 ]
Green, Celia [3 ]
Van Hazel, Guy [4 ]
Spagnolo, Dominic [3 ,5 ]
Cheah, Chan Yoon [1 ,2 ,5 ]
机构：
[1] Sir Charles Gairdner Hosp, Dept Haematol, Perth, WA, Australia
[2] Pathwest Lab Med, Perth, WA, Australia
[3] Pathwest Lab Med Western Australia, Dept Anat Pathol, Nedlands, WA, Australia
[4] Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia
[5] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia
来源：
EUROPEAN JOURNAL OF CANCER | 2019年 / 115卷
关键词：
D O I：
10.1016/j.ejca.2019.04.026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：84 / 87
页数：4
相关论文
共 50 条
  • [1] Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy
    Rajapakse, Pramuditha
    Andanamala, Haripriya
    WORLD JOURNAL OF ONCOLOGY, 2022, 13 (02) : 49 - 52
  • [2] Gene Therapy for Haemophagocytic Lymphohistiocytosis
    Booth, Claire
    Carmo, Marlene
    Gaspar, H. Bobby
    CURRENT GENE THERAPY, 2014, 14 (06) : 437 - 446
  • [3] Secondary haemophagocytic lymphohistiocytosis associated with metronidazole
    Iio, Kazuki
    Ariyama, Yuta
    Tomita, Hirofumi
    Sakakibara, Hiroshi
    Hataya, Hiroshi
    POSTGRADUATE MEDICAL JOURNAL, 2019, 95 (1125) : 390 - 390
  • [4] Secondary haemophagocytic lymphohistiocytosis in a young adult
    Moloney, Jayson
    Denton, Matthew
    PATHOLOGY, 2017, 49 (07) : 815 - 817
  • [5] Development of gene therapy for haemophagocytic lymphohistiocytosis (HLH) due to perforin deficiency
    Carmo, M.
    Booth, C.
    Montiel-Equihua, C. A.
    Schambach, A.
    Baum, C.
    Thrasher, A. J.
    Gaspar, H. B.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1455 - 1455
  • [6] Development of gene therapy for haemophagocytic lymphohistiocytosis (HLH) due to perforin deficiency
    Carmo, M.
    Montiel-Equihua, C. A.
    Schambach, A.
    Baum, C.
    Thrasher, A. J.
    Gaspar, H. B.
    HUMAN GENE THERAPY, 2011, 22 (10) : A46 - A47
  • [7] Secondary Acute Myeloid Leukemia After Etoposide Therapy for Haemophagocytic Lymphohistiocytosis
    RamaChandran, Shanti
    Ariffin, Hany
    PEDIATRIC BLOOD & CANCER, 2009, 53 (03) : 488 - 490
  • [8] DEVELOPMENT OF GENE THERAPY FOR HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) DUE TO PERFORIN DEFICIENCY
    Carmo, M.
    Arumugam, P.
    Montiel-Equiha, C.
    Alonso-Ferrero, M.
    Schambach, A.
    Baum, C.
    Risma, K.
    Malik, P.
    Thrasher, A.
    Jordan, M.
    Gaspar, B.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 131 - 131
  • [9] Acquired haemophagocytic lymphohistiocytosis secondary to multiple myeloma
    Bhatt, Ruchi
    Xiao, Shaun
    Gohari, Pouyan
    Podrumar, Alida
    BMJ CASE REPORTS, 2019, 12 (09)
  • [10] Haemophagocytic lymphohistiocytosis secondary to brucellosis in a young child
    Mittal, Jashan
    Kumar, Prawin
    Goyal, Jagdish Prasad
    Purohit, Abhishek
    BMJ CASE REPORTS, 2021, 14 (03)
12345